Platelet function preservation after intraoperative autologous blood donation in cardiac surgery

Platelet function preservation after intraoperative autologous blood donation in cardiac surgery - platelet preservation in cardiac surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31386

Enrollment

Registered

2008-01-29

Start date

2007-09-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

platelet function

Interventions

Comparison of autologous blood transfusion preserved in heparin (control group) against an alternative strategy (blood preserved in bivalirudin).

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: haemoglobin level of 8 mmol/L

Exclusion criteria

Exclusion criteria: use of platelet inhibitors

Design outcomes

Primary

Measure	Time frame
for part I, in vitro platelet function during period of cardio pulmonary bypass. for part II, reduction of blood loss and quality of clotting (Thromboelastogram and platelet function) after cardio pulmonary bypass.	—

Secondary

Measure	Time frame
quality and quantity of blood clotting and platelet function after 2 hours in Intensive Care. Rethroacotomies for increased blood loss	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)